Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging?
- 31 May 2008
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 130 (2) , 107-114
- https://doi.org/10.1016/j.jconrel.2008.05.024
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Shape effects of filaments versus spherical particles in flow and drug deliveryNature Nanotechnology, 2007
- Quantum Dots for Molecular PathologyThe Journal of Molecular Diagnostics, 2007
- Dendrimer-Based Targeted Delivery of an Apoptotic Sensor in Cancer CellsBiomacromolecules, 2006
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug deliveryMolecular Cancer Therapeutics, 2006
- Multi-functional polymeric nanoparticles for tumour-targeted drug deliveryExpert Opinion on Drug Delivery, 2006
- PAMAM Dendrimer-Based Multifunctional Conjugate for Cancer Therapy: Synthesis, Characterization, and FunctionalityBiomacromolecules, 2006
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptidesJournal of Controlled Release, 2003
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003